Purpose: To present a case of Maroteaux-Lamy syndrome (MLS), which underwent deep anterior lamellar keratoplasty (DALK) for visual rehabilitation.
M ucopolysaccharidosis (MPS) VI or Maroteaux-Lamy syndrome (MLS) is caused by impaired activity of the lysosomal enzyme N-acetylgalactosamine-4-sulfatase (4-sulfatase, arylsulfatase B, or ARSB; EC 3.1.6.1), resulting from mutations in the ARSB gene (MIM # 253200). 1 The clinical features of mucopolysaccharidosis result from lysosomal accumulation of partially degraded or undegraded glycosaminoglycans. Patients can present within a wide continuous clinical spectrum from slowly to rapidly advancing pathology. Symptoms include short stature, organomegaly, dysostosis multiplex, hernias, joint stiffness, cardiac abnormalities, and coarse face with/without intellectual impairment. Ocular manifestations include ptosis, significant progressive corneal opacification, acute and chronic angle-closure and open-angle glaucoma, optic nerve atrophy, and papilledema secondary to hydrocephalus. [2] [3] [4] [5] Significant and progressive appearance of ground glass is characteristic of corneal opacification in this syndrome. [6] [7] [8] This disease affects all layers of the cornea to some extent. Corneal epithelial cells and stromal keratocyte lysosomes have numerous vacuoles containing glycosaminoglycans. Epithelial basement membrane shows frequent breaks and peg-like undulations. Bowman layer is markedly attenuated. Anterior stromal scarring occurs in the middle and posterior stroma with abnormal morphology of keratocytes. Descemet membrane is usually normal. Corneal endothelial cells have normal morphology, but they may contain vacuolated lysosomal inclusions. 2, [9] [10] [11] [12] [13] [14] [15] [16] Current methods of corneal transplantation are penetrating keratoplasty (PKP) and deep anterior lamellar keratoplasty (DALK). PKP has been reported to provide good results in MPSs, especially in MPS-VI. 17, 18 However, to the best of our knowledge, there is no study in the literature evaluating outcomes of DALK in patients with MLS. This article reports the outcome of DALK in a patient with MPS-VI.
CASE REPORT
A 15-year-old girl was admitted with increasing glare and reduced vision affecting both eyes at Labbafinejad Medical Center. She had initially noticed her visual problems when she was 7 years old. Familiar consanguinity was reported between her parents. Physical examination disclosed marked growth retardation (105-cm height), dysplastic hips, joint stiffness, genu valgum, arrested hydrocephalus, anterior sternal protrusion, enlarged head with short neck, coarse face, prominent eyebrows, hyperplasic lips, hepatosplenomegaly, and normal intellectual function (Fig. 1) . The diagnosis of MPS-VI was made later based on low levels of leukocyte N-acetylgalactosamine-4-sulphatase, sulfatidase, and 4-methylumbelliferyl sulfatase sulphatase enzyme activity.
Her best spectacle-corrected visual acuity was counting fingers at 1.5 m in the right eye and counting fingers at 1 m in the left eye. External ocular examination was normal. On slit-lamp biomicroscopy, there was severe bilateral diffuse ground-glass stromal opacity (Figs. 2A, examination was difficult to perform. Electroretinography and visual evoked potential were normal in both eyes.
We decided to perform DALK on her left eye for visual rehabilitation. The big-bubble technique was used to perform lamellar separation. 19 The resulting lamellar bed was noted to be relatively clear. The Descemet membrane was stripped off the donor corneal button and an 8.0-mm lenticule trephined. This was secured over a 7.75-mm recipient corneal bed with continuous 10.0 nylon sutures. Patient received dexamethasone 0.1% and chloramphenicol 0.5% 4 times a day after surgery. The topical antibiotic was stopped 2 weeks postoperatively after epithelial healing. The topical steroid was tapered and reduced postoperatively to once a day at 3 months. Suture adjustment was carried out 2 months postoperatively. All sutures were removed 6 months after surgery. Histopathological study of corneal button revealed focal attenuation of Bowman layer with scattered foci of interlamellar deposition, stained with periodic acid-Schiff and Alcian blue.
Two years after surgery, corneal graft was clear (Figs. 3A, B) . Best spectacle-corrected visual acuity of the left eye was 20/25 (correction: +0.75/20.50 diopters 3 170). At the last follow-up, in vivo confocal scan (Confoscan 3.4; Nidek Technology, Padova, Italy) revealed unremarkable mild haze in posterior stroma at the graft interface level. The endothelial morphology was normal. Using a noncontact specular microscope (SP 3000P; Topcon) with the ImageNet imaging system (version 2.1; Topcon), the endothelial cell density was 2473.4 cells per square millimeter (normal range for her age: 2252-3797 cells per square millimeter) with coefficient of variations (CV) of 34.5% and hexagonality of 57%.
DISCUSSION
MLS is inherited as an autosomal recessive trait. 20 In most cases of MPS-VI, accumulation of dermatan sulfate in keratocytes results in corneal opacity. Vacuolated keratocytes and extracellular pools of acid mucopolysaccharides cause light scattering in these patients. 7, 21 The effect of this syndrome on endothelial cells is controversial. Some authors reported that corneal endothelial cells have normal morphology. 9, 16 Whereas, others have shown that they may contain vacuolated lysosomal inclusions. 10, [14] [15] [16] Putting together, endothelial cells have been reported from normal to degenerated with prominent nuclei in different studies. 2 It seems endothelial cells are the last part of cornea, which might be affected by this disease, especially in advanced stages. It remains to be seen whether or not the signs of degeneration and decompensation will develop in the endothelium over the course of disease in this case.
Although, some studies report progressive clearing of corneal stroma surrounding the corneal graft after corneal transplantation, 2,22 we did not observe such clearing effect in our case. Two years after surgery, confocal scan revealed mild stromal haze at the graft interface area. Our finding is in accordance with an experimental study by Aguirre et al. 23 They did not observe the clearing effect of host corneas after reciprocal corneal transplantation in a feline MPS-VI model. PKP has been reported to provide good results and long maintenance of a clear donor cornea in MPS-VI. 2, 17, 18 Clear grafts have been maintained for 13 years in a patient with MPS-VI after bone marrow transplant. 17 However, replacement of all 3 layers of the cornea may not be needed in these cases where the disease is mostly limited to stromal and epithelial layers. Lamellar keratoplasty aims to selectively replace the abnormal layers of the corneal stroma while preserving the host's endothelium, thereby eliminating the risk of endothelial graft rejection. 24, 25 Any coexistent retinopathy, glaucoma, and optic nerve disease must be fully evaluated in a patient with MPS before corneal transplantation. The potential benefits should be balanced with potential difficulties of intensive postoperative management with any complications and the significant anesthetic risks in patients with MPS. 2 It should be noticed that intraocular pressure measurements may be influenced by changes in corneal thickness. Diagnosis of glaucoma is also hampered by coexistent corneal opacification leading to difficulties in visualization of the angle structures and assessment of disc cupping. Patients may not be able to cooperate with visual field assessments, and the results will also be influenced by the presence of retinopathy. Therefore, managing these patients requires more care and attention. 3, 8 We had some limitations in this study. We were not able to perform an accurate endothelial cell count before surgery because of significant corneal opacity. More cases with longer follow-up are needed to judge the long-term outcomes of DALK in these patients. However, based on the results of this case, it seems DALK is a better choice in patients with MLS for visual rehabilitation.
